A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial

Rachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, Amaury Daste, Caroline Even, Philip Debruyne, Stéphanie Henry, Sylvie Zanetta, Anemie Rutten, Lisa Licitra, Jean-Luc Canon, Marie-Christine Kaminsky, Pol Specenier, Sylvie Rottey, Joël Guigay, Anthony Kong, Inge Tinhofer, Edith Borcoman, Lieve Dirix, Tiana Raveloarivahy, Catherine Fortpied, Maureen Vanlancker, Marie Morfouace, Anne-Sophie Govaerts, Jean-Pascal Machiels

Open source

DOI: 10.1016/j.ejca.2021.09.003
Published: 2021-11
Container: European Journal of Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2021.09.003,
  title = {A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial},
  author = {Rachel Galot and Christophe Le Tourneau and Esma Saada-Bouzid and Amaury Daste and Caroline Even and Philip Debruyne and Stéphanie Henry and Sylvie Zanetta and Anemie Rutten and Lisa Licitra and Jean-Luc Canon and Marie-Christine Kaminsky and Pol Specenier and Sylvie Rottey and Joël Guigay and Anthony Kong and Inge Tinhofer and Edith Borcoman and Lieve Dirix and Tiana Raveloarivahy and Catherine Fortpied and Maureen Vanlancker and Marie Morfouace and Anne-Sophie Govaerts and Jean-Pascal Machiels},
  year = {2021},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2021.09.003},
  url = {https://doi.org/10.1016/j.ejca.2021.09.003}
}

RIS

TY  - JOUR
TI  - A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
AU  - Rachel Galot
AU  - Christophe Le Tourneau
AU  - Esma Saada-Bouzid
AU  - Amaury Daste
AU  - Caroline Even
AU  - Philip Debruyne
AU  - Stéphanie Henry
AU  - Sylvie Zanetta
AU  - Anemie Rutten
AU  - Lisa Licitra
AU  - Jean-Luc Canon
AU  - Marie-Christine Kaminsky
AU  - Pol Specenier
AU  - Sylvie Rottey
AU  - Joël Guigay
AU  - Anthony Kong
AU  - Inge Tinhofer
AU  - Edith Borcoman
AU  - Lieve Dirix
AU  - Tiana Raveloarivahy
AU  - Catherine Fortpied
AU  - Maureen Vanlancker
AU  - Marie Morfouace
AU  - Anne-Sophie Govaerts
AU  - Jean-Pascal Machiels
PY  - 2021
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2021.09.003
UR  - https://doi.org/10.1016/j.ejca.2021.09.003
ER  -

APA

Galot, R., Tourneau, C. L., Saada-Bouzid, E., Daste, A., Even, C., Debruyne, P., Henry, S., Zanetta, S., Rutten, A., Licitra, L., Canon, J., Kaminsky, M., Specenier, P., Rottey, S., Guigay, J., Kong, A., Tinhofer, I., Borcoman, E., Dirix, L., Raveloarivahy, T., Fortpied, C., Vanlancker, M., Morfouace, M., Govaerts, A., & Machiels, J. (2021). A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2021.09.003

Source records

crossref · retrieved 2026-09-26T19:04:57.955Z